Levitan, B., Yuan, Z., Turpie, A. G., Friedman, R. J., Homering, M., Berlin, J. A., . . . DiBattiste, P. M. (2014). Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Dove Medical Press.
Čikaški stil citiranjaLevitan, Bennett, Zhong Yuan, Alexander GG Turpie, Richard J. Friedman, Martin Homering, Jesse A. Berlin, Scott D. Berkowitz, Rachel B. Weinstein, i Peter M. DiBattiste. Benefit–risk Assessment of Rivaroxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty. Dove Medical Press, 2014.
MLA način citiranjaLevitan, Bennett, et al. Benefit–risk Assessment of Rivaroxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty. Dove Medical Press, 2014.